| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3353539 | Immunity | 2010 | 12 Pages |
Abstract
Efforts to make vaccines against infectious diseases as well as immunotherapies for cancer, autoimmune diseases and allergy have utilized a variety of heterologous expression systems, including viral and bacterial vectors, as well as DNA and RNA constructs. This review explores the immunologic rationale and provides an update of insights obtained from preclinical and clinical studies of such vaccines.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Margaret A. Liu,